1 – 10 of 10
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Pooled Analysis of Meningioma Risk Following Treatment for Childhood Cancer
(
- Contribution to journal › Article
- 2019
-
Mark
Estimating CDKN2A mutation carrier probability among global familial melanoma cases using GenoMELPREDICT
(
- Contribution to journal › Article
- 2018
-
Mark
Phenocopies in melanoma-prone families with germ-line CDKN2A mutations
(
- Contribution to journal › Article
- 2017
-
Mark
Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families
(
- Contribution to journal › Article
- 2016
-
Mark
Multiple rare variants in high-risk pancreatic cancer-related genes may increase risk for pancreatic cancer in a subset of patients with and without germline CDKN2A mutations
(
- Contribution to journal › Article
-
Mark
Phenotypic and Histopathological Tumor Characteristics According to CDKN2A Mutation Status among Affected Members of Melanoma Families.
(
- Contribution to journal › Article
- 2012
-
Mark
Absolute Risk Prediction of Second Primary Thyroid Cancer Among 5-Year Survivors of Childhood Cancer.
2012) In Journal of Clinical Oncology(
- Contribution to journal › Article
- 2009
-
Mark
Selection criteria for genetic assessment of patients with familial melanoma
(
- Contribution to journal › Scientific review
- 2007
-
Mark
Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents
(
- Contribution to journal › Article
- 2006
-
Mark
High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL
(
- Contribution to journal › Article